35 Years since its first panels were stitched, The AIDS Memorial Quilt remains a powerful teaching tool for health action, remembrance and social justice
June 14, 2022 10:02 ET
|
National AIDS Memorial
San Francisco, CA, June 14, 2022 (GLOBE NEWSWIRE) -- It has been 35 years since the first panels of the AIDS Memorial Quilt were stitched together, sparking a national movement for action, justice...
Exavir Therapeutics announces publication of preclinical data for ultra-long-acting dolutegravir prodrug XVIR-120
June 09, 2022 07:00 ET
|
Exavir Therapeutics
Ultra-long-acting plasma pharmacokinetics and biodistribution to tissues of interest demonstrated in three species Injections were well tolerated with no adverse findings in preliminary toxicology...
Preclinical Data on Novel Arenaviral HIV Therapeutic Vaccines Presented at Keystone Symposium
June 03, 2022 07:00 ET
|
HOOKIPA Pharma Inc.
Oral and poster presentations highlight robust and high-quality immune responses following administration of novel arenaviral therapeutic vaccines in preclinical setting Alternating 2-vector...
Exavir Therapeutics Completes $4M Seed Financing from Key Investors
May 23, 2022 07:00 ET
|
Exavir Therapeutics
NEW YORK and OMAHA, Neb., May 23, 2022 (GLOBE NEWSWIRE) -- Exavir Therapeutics, a company dedicated to transforming the lives of people living with or at risk of acquiring HIV, today announced that...
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2022 Financial Results on May 5, 2022
April 21, 2022 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, April 21, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter...
Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit
April 05, 2022 06:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, April 05, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced...
Vir Biotechnology to Participate in the 21st Annual Needham Healthcare Conference
April 04, 2022 16:02 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company will participate in a fireside chat at the 21st Annual Needham Healthcare...
Global Infectious Disease Diagnostics Market Size to Increase by USD 41,291.40 Million| Top Spending Regions and Market Price Trends| Vantage Market Research
March 21, 2022 04:20 ET
|
Vantage Market Research
WASHINGTON, March 21, 2022 (GLOBE NEWSWIRE) -- According to a new market research report " Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Product (Reagents, Kits,...
Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
March 15, 2022 07:00 ET
|
Enochian BioSciences, Inc.
LOS ANGELES, March 15, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, has...
Minnesota Delegation visits 2020 World Expo in Dubai as campaign efforts build to host a Specialized Expo in 2027
February 17, 2022 09:00 ET
|
Minnesota USA Expo 2027
MINNEAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- As support grows for Minnesota to host a Specialized World Expo on global health in 2027, members of the official bid committee head to Dubai for the...